Business
Press Release Sep 07 2022
Cipla Limited has informed the Exchange about press release dated 07-Sep-2022 titled Cipla receives USFDA approval for the generic version of Revlimid�� (Lenalidomide capsules)
About this update from Cipla Ltd
[{"type":"text","content":" Cipla Limited has informed the Exchange about press release dated 07-Sep-2022 titled Cipla receives USFDA approval for the generic version of Revlimid�� (Lenalidomide capsules) View Attachment","length":391,"tagName":"div"}]